Published in N Engl J Med on December 03, 1998
RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System | NCT00736086
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA (2010) 6.29
Coronary-artery stents--gauging, gorging, and gouging. N Engl J Med (1998) 1.78
In stent restenosis: bane of the stent era. J Clin Pathol (2006) 1.71
Clinical pharmacogenetics implementation: approaches, successes, and challenges. Am J Med Genet C Semin Med Genet (2014) 1.57
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int (2006) 1.47
Restrictive access to clopidogrel and mortality following coronary stent implantation. CMAJ (2008) 1.46
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA (2012) 1.43
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Circulation (2016) 1.43
Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality. CMAJ (2000) 1.36
Drug points: Ticlopidine associated with acute arthritis. BMJ (2002) 1.33
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 1.31
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J (2015) 1.29
PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J Biol Chem (2006) 1.27
The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol (2011) 1.14
In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. Br J Clin Pharmacol (2000) 1.08
Risk factors and complications following percutaneous endoscopic gastrostomy: a case series of 1041 patients. Can J Gastroenterol (2011) 1.05
Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med (2000) 1.00
Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues. Heart (2004) 1.00
New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures. CMAJ (2002) 0.97
A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans. Br J Clin Pharmacol (2006) 0.96
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol (2013) 0.92
Leo stent for endovascular treatment of broad-necked and fusiform intracranial aneurysms. Interv Neuroradiol (2007) 0.87
Managing adverse effects and drug-drug interactions of antiplatelet agents. Nat Rev Cardiol (2011) 0.84
Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures. J Gastroenterol (2005) 0.84
Safe and feasible immediate retransfer of patients to the referring hospital after acute coronary angiography and percutaneous coronary angioplasty for patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care (2013) 0.84
Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2. PLoS One (2015) 0.82
Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy. Cardiol Res Pract (2012) 0.81
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. Am Heart J (2012) 0.81
Newer antithrombotic drugs. Indian J Crit Care Med (2010) 0.81
Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerations. Pharmacoeconomics (2013) 0.81
P2Y12-ADP receptor antagonists: Days of future and past. World J Cardiol (2016) 0.80
Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement? Curr Control Trials Cardiovasc Med (2000) 0.80
Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents. Nanomedicine (Lond) (2015) 0.80
The decline effect in cardiovascular medicine: is the effect of cardiovascular medicine and stent on cardiovascular events decline over the years? Korean Circ J (2013) 0.80
Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI. Curr Cardiol Rev (2012) 0.79
Intervention in coronary artery disease. Heart (2000) 0.79
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention. Curr Control Trials Cardiovasc Med (2001) 0.79
Antiplatelet combinations for prevention of atherothrombotic events. Vasc Health Risk Manag (2011) 0.79
Anticoagulation after anterior myocardial infarction and the risk of stroke. PLoS One (2010) 0.78
Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits. PLoS One (2015) 0.78
TRITON and beyond: new insights into the profile of prasugrel. Cardiovasc Ther (2011) 0.77
Cocaine-induced coronary stent thrombosis. Exp Clin Cardiol (2013) 0.77
High P-selectin expression and low CD36 occupancy on circulating platelets are strong predictors of restenosis after coronary stenting in patients with coronary artery disease. Heart Vessels (2007) 0.77
The impact of generic form of Clopidogrel on cardiovascular events in patients with coronary artery stent: results of the OPCES study. J Res Med Sci (2011) 0.77
Effect of balloon inflation time on expansion of sirolimus-eluting stent. Heart Vessels (2009) 0.77
Genetic determinations of variable responsiveness to clopidogrel and implications for neurointerventional procedures. Interv Neurol (2012) 0.76
Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute. Scientifica (Cairo) (2014) 0.76
Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention. Anesthesiology (2014) 0.76
Clinical features of early recurrent myocardial infarction. Heart Vessels (2009) 0.75
CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents. Medicine (Baltimore) (2016) 0.75
Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis. PLoS One (2011) 0.75
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Relat Outcome Meas (2010) 0.75
Use of antiplatelet inhibitors in peripheral vascular interventions. Semin Intervent Radiol (2005) 0.75
Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol (2011) 0.75
Update in internal medicine. Arch Med Res (2000) 0.75
Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses. CADTH Technol Overv (2012) 0.75
How I treat patients with inherited bleeding disorders who need anticoagulant therapy. Blood (2016) 0.75
The use of anticoagulation in pediatric cardiac disease. Images Paediatr Cardiol (2003) 0.75
Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). Vasc Health Risk Manag (2006) 0.75
Balancing antiplatelet and anticoagulant therapies in patients with cardiovascular disease. Cardiol Ther (2013) 0.75
New treatment possibilities for patients with advanced coronary artery disease and critical limb ischemia - a feasibility study. Postepy Kardiol Interwencyjnej (2016) 0.75
Managing Antiplatelet Therapy and Anticoagulants in Patients with Coronary Artery Disease and Atrial Fibrillation. J Atr Fibrillation (2015) 0.75
Antiplatelet use in interventional cardiology. Postgrad Med J (2000) 0.75
Attending to links in the safety chain for drug-eluting stents. Neth Heart J (2006) 0.75
Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute. Can J Cardiol (2007) 0.75
Stent thrombosis is a major concern in clinical practice: A single Saudi center experience. J Saudi Heart Assoc (2013) 0.75
Fortnightly review: Intracoronary stents. BMJ (1999) 0.75
Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial. Iran Red Crescent Med J (2014) 0.75
Advances in drug eluting stents - focus on the Endeavor(®) zotarolimus stent. Med Devices (Auckl) (2008) 0.75
Arterial access and arteriotomy site closure devices. Nat Rev Cardiol (2016) 0.75
A Case Report of Recurrent Subacute Stent Thrombosis After Drug Eluting Stent Implantation: What Is the Real Reason? Cardiol Res (2015) 0.75
Antithrombotic therapy after coronary-artery stenting. N Engl J Med (1999) 0.75
Antithrombotic therapy for patients with STEMI undergoing primary PCI. Nat Rev Cardiol (2017) 0.75
Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol (2014) 0.75
Prevention of stent thrombosis: challenges and solutions. Vasc Health Risk Manag (2015) 0.75
'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting. Neth Heart J (2010) 0.75
Single or dual antiplatelet therapy after PCI. Nat Rev Cardiol (2017) 0.75
Bleeding complication of triple therapy of rivaroxaban, prasugrel, and aspirin: a case report and general discussion. Case Rep Cardiol (2014) 0.75
Triple antithrombotic therapy for atrial fibrillation and coronary stents. Can Fam Physician (2017) 0.75
[Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy]. Z Kardiol (2004) 0.75
Biomarkers in acute coronary artery disease. Wien Med Wochenschr (2012) 0.75
Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitors. Korean J Anesthesiol (2017) 0.75
Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina. J Thromb Thrombolysis (2017) 0.75
Paradigm shift in anticoagulation therapy, fueling the pump and preventing rhythm crisis. J Thorac Dis (2017) 0.75
Trials of newer approaches to anticoagulation in atrial fibrillation. J Interv Card Electrophysiol (2004) 0.75
In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis. J Mater Sci Mater Med (2011) 0.75
The dawn of neurosurgery in pre-conquest Mesoamerican territories. Childs Nerv Syst (2017) 0.75
[Coronary stent thrombosis: what's new in 2011?]. Herz (2011) 0.75
Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study. Curr Ther Res Clin Exp (2017) 0.75
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) (1981) 14.25
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation (1999) 8.17
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med (1992) 7.33
Diagnosis of growth-hormone deficiency in adults. Lancet (1994) 5.93
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Cardiac surgery report cards: comprehensive review and statistical critique. Ann Thorac Surg (2001) 4.26
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation (1996) 3.58
Can meta-analyses be trusted? Lancet (1991) 3.43
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation (1994) 3.30
Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J (1979) 3.29
Cocaine-induced coronary-artery vasoconstriction. N Engl J Med (1989) 3.04
An epidemiological study of workers producing enzyme washing powders. Lancet (1970) 2.98
Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med (1997) 2.86
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
Can coronary flow parameters after stent placement predict restenosis? Cathet Cardiovasc Diagn (1995) 2.69
Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation (2001) 2.66
Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation (2001) 2.60
Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation (1983) 2.59
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med (2001) 2.54
Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol (1982) 2.54
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation (1994) 2.44
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation (1991) 2.23
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med (1993) 2.18
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14
Allocation of patients to treatment in clinical trials. Biometrics (1979) 2.13
On the design and analysis of randomized clinical trials with multiple endpoints. Biometrics (1993) 2.13
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol (2001) 2.12
Myonecrosis after revascularization procedures. J Am Coll Cardiol (1998) 2.11
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv (2001) 2.08
Transcatheter closure of ventricular septal defects. Circulation (1988) 2.05
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation (1997) 2.05
Extravasation of thrombus into the aortic root: a complication following use of an infusion catheter for intragraft thrombolysis. Cathet Cardiovasc Diagn (1996) 2.03
Short-term effects of air pollution on daily mortality in Athens: a time-series analysis. Int J Epidemiol (1994) 2.03
Effects of alcohol and smoking on blood lead in middle-aged British men. Br Med J (Clin Res Ed) (1982) 2.03
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
The combination of randomized and historical controls in clinical trials. J Chronic Dis (1976) 2.00
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99
Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry. Circulation (1993) 1.98
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation (1994) 1.98
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation (1991) 1.96
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol (1995) 1.93
Transcatheter closure of coronary artery fistulas. J Am Coll Cardiol (1992) 1.93
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation (2001) 1.91
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation (1987) 1.89
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
Biochemical and haematological response to alcohol intake. Ann Clin Biochem (1985) 1.84
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol (1992) 1.82
Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn (1992) 1.82
British blood cholesterol values and the American consensus. Br Med J (Clin Res Ed) (1985) 1.80
Blood pressure and hypertension in middle-aged British men. J Hypertens (1988) 1.80
Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. BMJ (1991) 1.79
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J Med (1991) 1.78
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 1.73
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation (1990) 1.73